UTI Mutual Fund Pharma Fund - Regular Plan - Growth

UTI Mutual Fund Pharma Fund - Regular Plan - Growth – Poora parichay aur strategy

UTI Mutual Fund Pharma Fund - Regular Plan - Growth ek equity mutual fund hai jo primarily pharma sector mein invest karta hai. Iska main objective hai long-term capital appreciation, jo ki healthcare aur pharmaceutical industry ki growth se achieve kiya jata hai. Ye fund un investors ke liye suitable hai jo high growth potential wale sectors mein invest karna chahte hain aur unhe market volatility se koi dikkat nahi hai. Is fund ki strategy mein sectoral concentration hai, jo ki pharmaceutical stocks ki performance par depend karta hai. Kya aapko lagta hai ye aapke liye sahi hai? Chaliye aur details dekhte hain!

UTI Mutual Fund Pharma Fund - Regular Plan - Growth ke returns – 1, 3, 5 saal ke aankde

Chaliye ab baat karte hain UTI Mutual Fund Pharma Fund - Regular Plan - Growth ke returns ki. Fund ne pichle saalon mein kuch interesting returns diye hain:

Period	UTI Mutual Fund Pharma Fund - Regular Plan - Growth Returns	Benchmark (Nifty Pharma TRI)
1 Year	1.38%	2.30%
3 Years	11.31%	10.00%
5 Years	10.05%	9.50%

Agar hum 1 saal ke returns ko dekhe, toh fund ne 1.38% ki return di hai, jo benchmark se thodi kam hai. Lekin 3 saal aur 5 saal ke returns mein isne benchmark ko outperform kiya hai, jo ki consistency dikhata hai. Fund manager V. Srivatsa ki strategy aur market conditions ke hisaab se ye returns kaafi promising lagte hain. Investors jo long-term wealth creation ke liye soch rahe hain, unhe is fund ke performance pe dhyan dena chahiye.

UTI Mutual Fund Pharma Fund - Regular Plan - Growth portfolio breakdown for investors

UTI Mutual Fund Pharma Fund - Regular Plan - Growth ki portfolio mein kuch top holdings hain, jo fund ki performance ko drive karti hain: - **Sun Pharmaceutical Industries Ltd.** (20.5%) - **Dr. Reddy's Laboratories Ltd.** (12.8%) - **Cipla Ltd.** (10.4%) - **Divi's Laboratories Ltd.** (9.8%) - **Torrent Pharmaceuticals Ltd.** (7.2%) Ye top holdings milkar fund ki overall performance par kaafi impact dalti hain. Iske alawa, fund ka sector allocation bhi kaafi interesting hai, kyunki ye overall healthcare market ke trends ko follow karta hai. Agar aap pharma sector ki growth potential mein yakin rakhte hain, toh ye fund aapke portfolio ko diversify karne ka ek accha option ho sakta hai.

UTI Mutual Fund Pharma Fund - Regular Plan - Growth risk analysis and volatility

UTI Mutual Fund Pharma Fund - Regular Plan - Growth ka riskometer "Very High" hai, jo dikhata hai ki is fund ki volatility kaafi high hai. Agar aap risk-averse investor hain, toh shayad ye fund aapke liye nahi hoga. Is fund ki high-risk nature iske concentrated investments aur market dynamics se judi hui hai. Isliye, agar aap long-term investor hain aur high returns ki talash mein hain, toh aap is fund ko consider kar sakte hain. Lekin, hamesha yaad rahe ki is type ke funds mein invest karne se pehle apni risk tolerance ko samajhna zaroori hai.

UTI Mutual Fund Pharma Fund - Regular Plan - Growth pros and cons for investors

• High growth potential due to sector focus.
• Strong past performance in the long term.
• Diversified exposure to pharmaceutical companies.
• Managed by experienced fund manager V. Srivatsa.

• High expense ratio of 1.95%.
• High risk and volatility associated with pharma stocks.
• 1-year returns lagging behind benchmark.